M. Raluy-Callado

First name
Last name
Cid-Ruzafa, J., Lacy, B. E., Schultze, A., Duong, M., Lu, Y., Raluy-Callado, M., et al. (2022). Linaclotide utilization and potential for off-label use and misuse in three European countries. Therap Adv Gastroenterol, 15, 17562848221100946. http://doi.org/10.1177/17562848221100946
Khalid, J. M., Raluy-Callado, M., Curtis, B. H., Boye, K. S., Maguire, A., & Reaney, M. (2014). Rates and risk of hospitalisation among patients with type 2 diabetes: retrospective cohort study using the UK General Practice Research Database linked to English Hospital Episode Statistics. Int J Clin Pract. http://doi.org/10.1111/ijcp.12265
Lambrelli, D., Burge, R., Raluy-Callado, M., . Y. Chen, S., Wu, N., & Schoenfeld, M. J. (2014). Retrospective database study to assess the economic impact of hip fracture in the United Kingdom. J Med Econ. http://doi.org/10.3111/13696998.2014.959588
Ilo, D., Raluy-Callado, M., Graham-Clarke, P., Sadasivan, R., Birt, J., Donaldson, R., et al. (2015). Patient characteristics and treatment patterns for patients with benign prostatic hyperplasia, erectile dysfunction or co-occurring benign prostatic hyperplasia and erectile dysfunction in general practices in the UK: a retrospective observational study. Int J Clin Pract. http://doi.org/10.1111/ijcp.12657
van Brunt, K., Curtis, B., Ivanyi, T., Balogh, E., Chalkiadaki, C., MacLachlan, S., et al. (2016). Basal-bolus Therapy in Patients with Type 2 Diabetes Mellitus in the UK: Patient Characteristics, Treatment Patterns and the Effect of Switching to Premixed Insulin. Diabetes Ther. http://doi.org/10.1007/s13300-016-0209-4
Merinopoulou, E., Raluy-Callado, M., Ramagopalan, S., MacLachlan, S., & Khalid, J. M. (2016). COPD exacerbations by disease severity in England. Int J Chron Obstruct Pulmon Dis. http://doi.org/10.2147/copd.s100250
Ramagopalan, S. V., Graham, S., Carroll, R., Raluy-Callado, M., Nordstrom, B. L., Donaldson, R., et al. (2019). Discontinuation and primary care visits in nonvalvular atrial fibrillation patients treated with apixaban or warfarin. J Comp Eff Res. http://doi.org/10.2217/cer-2019-0005